Results 61 to 70 of about 3,359 (196)

Recurrent malignant struma ovarii presenting as peritoneal carcinomatosis in the setting of an intact thyroid: A case report and review of the literature

open access: yesGynecologic Oncology Reports
Malignant struma ovarii is an exceedingly rare pathology with a paucity of established criteria regarding management and surveillance with recommendations largely based on case reports and retrospective data. Many authors have supported stratification of
Morgan Brown   +6 more
doaj   +1 more source

O‐RADS MRI SCORE: An Essential First‐Step Tool for the Characterization of Adnexal Masses

open access: yesJournal of Magnetic Resonance Imaging, Volume 59, Issue 3, Page 720-736, March 2024.
The ovarian‐adnexal reporting and data system on magnetic resonance imaging (O‐RADS MRI) score is now a well‐established tool to characterize pelvic gynecological masses based on their likelihood of malignancy. The main added value of O‐RADS MRI over O‐RADS US is to correctly reclassify lesions that were considered suspicious on US as benign on MRI ...
I. Thomassin‐Naggara   +6 more
wiley   +1 more source

Struma Ovarii - A Case Report

open access: yes, 2017
Struma ovarii (literally: goitre of the ovary) is a rare form of monodermal teratoma that contains mostly thyroid tissue. The vast majority are benign tumours; however, malignant tumours of this type is found in a small percentage of cases.
Md Shamim Farooq   +1 more
core   +1 more source

Malignant Struma Ovarii: Case Report and a Review of the Literature [PDF]

open access: yes, 2013
Struma ovarii is a rare tumor. Malignant change in this tumour is even rarer. While clinical presentation is protean, a preoperative diagnosis is equally difficult. Diagnosis is confirmed by histology.
Olusina, DB   +3 more
core   +1 more source

Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii

open access: yesHistopathology, Volume 84, Issue 2, Page 291-300, January 2024.
Benign struma ovarii shows significantly fewer molecular alterations than malignant struma. BRAF and TERT promoter mutations are seen only in malignant tumours. BRAF p.G469A mutation is frequent in struma ovarii, while rare in thyroid gland carcinomas. Gene sequencing may help in classifying and predicting the clinical outcome of struma ovarii.
Sophie Neyrand   +8 more
wiley   +1 more source

Bilateral benign non functional struma ovarii with Pseudo-Meigs′ syndrome

open access: yesIndian Journal of Pathology and Microbiology, 2009
Bilateral presentation of benign Struma ovarii is rare and has not been reported frequently in published literature. A 70-year-old postmenopausal female presented with progressive ascites, bilateral pleural effusion and elevated CA-125 levels.
Rana Vandana   +4 more
doaj  

Asymptomatic struma ovarii: A case report

open access: yes, 2005
Struma ovarii is a rare ovarian neoplasm. This tumor is generally benign, although malignant transformation has been reported. The preoperative diagnosis is generally difficult.
D. Pallante   +4 more
core  

The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes

open access: yes
Journal of Ultrasound in Medicine, Volume 44, Issue 11, Page 2133-2146, November 2025.
Roni Yoeli‐Bik   +6 more
wiley   +1 more source

A rare ovarian tumour, struma ovarii [PDF]

open access: yes, 2016
Struma ovarii is a rare entity, with about 200 reported cases in the medical literature. Struma ovarii is a specialized monodermal teratoma, predominantly composed of mature thyroid tissue. Only 5-8% has functional thyroid tissue.
Dasharatha, Murmu   +3 more
core   +1 more source

of Struma Ovarii: A Rare Ovarian Tumor [PDF]

open access: yes, 2020
Struma ovarii or monodermal teratoma is a specialized ovarian neoplasm which mainly constitutes mature thyroid tissue. It is a rare tumor which comprises 1% of all ovarian tumors and 2.7% of all dermoid tumors.
Manish Kiran Shrestha   +8 more
core  

Home - About - Disclaimer - Privacy